Benjamin Petrinec

Northeast Ohio Medical University, Emory University

Papers

Total Citations

H-Index

About

Benjamin Petrinec is a surgeon-scientist advancing the field of urologic oncology, with a focused expertise in minimally invasive surgical approaches for genitourinary cancers. His primary research centers on refining inguinal lymph node dissection (ILND) for penile cancer, a procedure critical for staging and treatment but historically associated with significant morbidity. Petrinec’s major contributions include systematically evaluating the benefits of laparoscopic and robotic-assisted ILND, demonstrating that these techniques reduce complications—such as wound infections and lymphedema—while maintaining oncologic efficacy. His most cited work, "Inguinal lymph node dissection in the era of minimally invasive surgical technology" (2020, 31 citations), synthesizes evidence to position these approaches as viable alternatives to open surgery. A companion study, "Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer" (2020, 15 citations), further reviews surgical outcomes and techniques, highlighting improved recovery times and lower morbidity. With a cumulative citation count exceeding 46, Petrinec’s research is shaping clinical guidelines and empowering surgeons to adopt less invasive methods. His work stands as a pivotal resource for trainees and practitioners seeking to optimize care for penile cancer patients, blending technical innovation with patient-centered outcomes.